Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


13.02.2017

5 Am J Gastroenterol
1 Am J Pathol
3 Ann Intern Med
6 Anticancer Res
1 Biochem Biophys Res Commun
2 BMC Gastroenterol
1 Dig Dis Sci
7 Eur Radiol
3 Gastroenterology
2 Gut
4 Hepatology
1 Indian J Gastroenterol
2 J Gastroenterol Hepatol
2 J Hepatol
1 J Pediatr
1 N Engl J Med
1 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. LO GH
    Did Statins Really Reduce the Risk of Cirrhosis and Decompensation in Chronic Hepatitis B Patients?
    Am J Gastroenterol. 2017;112:386-387.
    PubMed     Text format    

  2. YANG JD, Mohamed HA, Cvinar JL, Gores GJ, et al
    Corrigendum: Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Am J Gastroenterol. 2017;112:402.
    PubMed     Text format    

  3. TAKYAR V, Kleiner DE, Koh C
    A Wolf in Sheep's Clothing in the Era of Non-Invasive Staging: Non-Hodgkin's Lymphoma Masquerading as Serologic HCV Cirrhosis.
    Am J Gastroenterol. 2017;112:398-399.
    PubMed     Text format    

  4. SLIM M, Ruiz-Cabello E, Robles-Diaz M, Lucena MI, et al
    A New Hepatoprotective Effect of Statins: Are They Always Safe for the Liver?
    Am J Gastroenterol. 2017;112:384-385.
    PubMed     Text format    

  5. HU Y, Hu D, Fu R
    Statins Reduce the Risk of Cirrhosis and its Decompensation in CHB Patients?
    Am J Gastroenterol. 2017;112:383.
    PubMed     Text format    


    Am J Pathol

  6. YANG Z, Liu Y, Qin L, Wu P, et al
    Cathepsin H-Mediated Degradation of HDAC4 for Matrix Metalloproteinase Expression in Hepatic Stellate Cells: Implications of Epigenetic Suppression of Matrix Metalloproteinases in Fibrosis through Stabilization of Class IIa Histone Deacetylases.
    Am J Pathol. 2017 Jan 31. pii: S0002-9440(17)30022.
    PubMed     Text format     Abstract available


    Ann Intern Med

  7. SUTTON SK
    Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis.
    Ann Intern Med. 2017;166:229.
    PubMed     Text format    

  8. BRIL F, Cusi K
    Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis.
    Ann Intern Med. 2017;166:230.
    PubMed     Text format    

  9. THOMAS JA, Gupta R, Aithal GP
    Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis.
    Ann Intern Med. 2017;166:229-230.
    PubMed     Text format    


    Anticancer Res

  10. ZHANG S, Tang D, Zang W, Yin G, et al
    Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:465-473.
    PubMed     Text format     Abstract available

  11. ZENG H, Wu HC, Wang Q, Yang HI, et al
    Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort.
    Anticancer Res. 2017;37:637-644.
    PubMed     Text format     Abstract available

  12. CHEN YL, Huang WC, Yao HL, Chen PM, et al
    Down-regulation of RASA1 Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:781-785.
    PubMed     Text format     Abstract available

  13. FRIEDMAN P, Lai JP
    Liver Metastasis of Urothelial Carcinoma with Hepatoid Features: An Unusual Morphological Finding.
    Anticancer Res. 2017;37:801-804.
    PubMed     Text format     Abstract available

  14. IKEGAMI T, Yoshizumi T, Kawasaki J, Nagatsu A, et al
    Surgical Resection for Lymph Node Metastasis After Liver Transplantation for Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:891-895.
    PubMed     Text format     Abstract available

  15. ALT M, Truant S, Renaud-Vantroys T, Sequier C, et al
    Bevacizumab Associated with Chemotherapy for Initially Non-resectable Liver Metastases from Colorectal Cancer: a Case-Control Study.
    Anticancer Res. 2016;36:5551-5555.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  16. YUE L, Li L, Li D, Yang Z, et al
    High-throughput screening for Survivin and Borealin interaction inhibitors in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2017 Jan 31. pii: S0006-291X(17)30241.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  17. SHERID M, Samo S, Sulaiman S, Husein H, et al
    Liver abscess and bacteremia caused by lactobacillus: role of probiotics? Case report and review of the literature.
    BMC Gastroenterol. 2016;16:138.
    PubMed     Text format     Abstract available

  18. SOBHONSLIDSUK A, Poovorawan K, Soonthornworasiri N, Pan-Ngum W, et al
    The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study.
    BMC Gastroenterol. 2016;16:135.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  19. KIM G, Huh JH, Lee KJ, Kim MY, et al
    Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2017 Feb 7. doi: 10.1007/s10620-017-4471.
    PubMed     Text format     Abstract available


    Eur Radiol

  20. ROUSSET P, Gregory J, Rousset-Jablonski C, Hugon-Rodin J, et al
    MR diagnosis of diaphragmatic endometriosis.
    Eur Radiol. 2016;26:3968-3977.
    PubMed     Text format     Abstract available

  21. VILGRAIN V, Esvan M, Ronot M, Caumont-Prim A, et al
    A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.
    Eur Radiol. 2016;26:4595-4615.
    PubMed     Text format     Abstract available

  22. ZECH CJ, Justo N, Lang A, Ba-Ssalamah A, et al
    Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.
    Eur Radiol. 2016;26:4121-4130.
    PubMed     Text format     Abstract available

  23. JAKOBS TF, Paprottka KJ, Raessler F, Strobl F, et al
    Robust evidence for long-term survival with 90Y radioembolization in chemorefractory liver-predominant metastatic colorectal cancer.
    Eur Radiol. 2017;27:113-119.
    PubMed     Text format     Abstract available

  24. VAN DEN HOVEN AF, Braat MN, Prince JF, van Doormaal PJ, et al
    Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol.
    Eur Radiol. 2017;27:61-69.
    PubMed     Text format     Abstract available

  25. BANNAS P, Bookwalter CA, Ziemlewicz T, Motosugi U, et al
    Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.
    Eur Radiol. 2017;27:32-40.
    PubMed     Text format     Abstract available

  26. KIM TH, Kim SH, Lee KB, Han JK, et al
    Outcome and CT differentiation of gallbladder neuroendocrine tumours from adenocarcinomas.
    Eur Radiol. 2017;27:507-517.
    PubMed     Text format     Abstract available


    Gastroenterology

  27. HUANG Z, Zhang F, Luo Z
    Intrahepatic Biliary Duct Dilatation With an Unusual Choledochoscope Image.
    Gastroenterology. 2017 Jan 31. pii: S0016-5085(16)35177.
    PubMed     Text format    

  28. RAVI S, Axley P, Jones D, Kodali S, et al
    Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Gastroenterology. 2017 Feb 1. pii: S0016-5085(16)35535.
    PubMed     Text format    

  29. MATSUURA K, Sawai H, Ikeo K, Ogawa S, et al
    Genome-wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Gastroenterology. 2017 Feb 2. pii: S0016-5085(17)30130.
    PubMed     Text format     Abstract available


    Gut

  30. VAN RENNE N, Roca Suarez AA, Duong FH, Gondeau C, et al
    miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis.
    Gut. 2017 Feb 3. pii: gutjnl-2016-312270. doi: 10.1136/gutjnl-2016-312270.
    PubMed     Text format     Abstract available

  31. BRUNT EM, Kleiner DE
    Challenges in the hepatic histopathology in non-alcoholic fatty liver disease.
    Gut. 2017 Feb 3. pii: gutjnl-2016-313379. doi: 10.1136/gutjnl-2016-313379.
    PubMed     Text format    


    Hepatology

  32. FERNANDEZ CARRILLO C, Lens S, Llop E, Pascasio JM, et al
    Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of MELD: Analysis of data from the Hepa-C registry.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29097.
    PubMed     Text format     Abstract available

  33. LEE MW, Raman SS, Asvadi NH, Siripongsakun S, et al
    Radiofrequency Ablation of Hepatocellular Carcinoma as Bridge Therapy to Liver Transplantation: A Ten Year Intention-to-treat Analysis.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29098.
    PubMed     Text format     Abstract available

  34. CADIER B, Bulsei J, Nahon P, Seror O, et al
    Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.28961.
    PubMed     Text format     Abstract available

  35. KRAWCZYK M, Rau M, Grunhage F, Schattenberg JM, et al
    The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.29100.
    PubMed     Text format    


    Indian J Gastroenterol

  36. KUMAR R, Kumar P, Saxena KN, Mishra M, et al
    Vitamin D status in patients with cirrhosis of the liver and their relatives-A case control study from North India.
    Indian J Gastroenterol. 2017 Feb 8. doi: 10.1007/s12664-017-0727.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  37. LYON KC, Likar E, Martello JL, Regier M, et al
    Retrospective Cross-Sectional Pilot Study of Rifaximin Dosing for the Prevention of Recurrent Hepatic Encephalopathy.
    J Gastroenterol Hepatol. 2017 Feb 8. doi: 10.1111/jgh.13759.
    PubMed     Text format     Abstract available

  38. SAWAHARA H, Shiraha H, Uchida D, Kato H, et al
    Promising therapeutic efficacy of a novel REIC/Dkk-3 expressing adenoviral vector for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2017 Feb 6. doi: 10.1111/jgh.13757.
    PubMed     Text format     Abstract available


    J Hepatol

  39. PRENNER S, VanWagner LB, Flamm SL, Salem R, et al
    Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Virus Therapy with Direct-Acting Antivirals.
    J Hepatol. 2017 Feb 1. pii: S0168-8278(17)30053.
    PubMed     Text format     Abstract available

  40. YANG C, Luo AL
    Myokines: a promising therapeutic target for hepaticencephalopathy.
    J Hepatol. 2017 Feb 3. pii: S0168-8278(17)30057.
    PubMed     Text format    


    J Pediatr

  41. SOKOLLIK C, Kreiter B, Wolf R
    Neonatal Hemochromatosis: Blitz Diagnosis Results in Favorable Outcome.
    J Pediatr. 2017 Feb 1. pii: S0022-3476(17)30049.
    PubMed     Text format    


    N Engl J Med

  42. OLSON KR, Davarpanah AH, Schaefer EA, Elias N, et al
    Case 2-2017. An 18-Year-Old Woman with Acute Liver Failure.
    N Engl J Med. 2017;376:268-278.
    PubMed     Text format    


    Oncogene

  43. LIN Y, Yang X, Liu W, Li B, et al
    Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: